News about hearing aids, hearing loss, cochlear implants, and more
Page 20 of 34
)
Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus.
)
HearingTracker interviews Oticon President Gary Rosenblum about the company's newest flagship hearing aid, Oticon Real, as well as BrainHearing, DNN, and the Polaris R platform that drives technology in the new device.
)
On World Hearing Day, the Hear Well campaign is premiering the “Take 3 For Me Hearing Challenge,” an online hearing screening adapted from the Hearing Handicap Inventory-Screening Version (HHIE-S) with input and review by audiologists.
)
Starkey Hearing Technologies believes its new Genesis AI hearing aid—and the chip platform powering it—will define AI-assisted hearing healthcare for years to come. Here are highlights of the new device and a summary of the company's launch event at Starkey headquarters in Minneapolis.
)
Starkey unveiled its new Genesis AI hearing aid which boasts a smaller, faster, and more efficient and powerful processor, new sleek design, an additive slow/fast compression system, new My Starkey app, and all-new Pro Fit fitting software for clinicians.
)
Today, Oticon launched its new Oticon Real hearing aid that provides access to the full spectrum of real-world sounds with exceptional detail and clarity while protecting against sudden disruptive sounds so users can stay comfortable and sharp in the real world.
)
Cochlear Limited's implants will now offer Audio Streaming for Hearing Aids (ASHA) support on compatible Fire TV devices. This is reportedly the first time a smart TV device streams sound directly to a hearing implant sound processor.
)
Frequency Therapeutics Inc. has announced the cessation of its FX-322 and FX-345 programs designed to help people with sudden or noise-induced sensorineural hearing loss (SNHL) only a few months after biotech hearing loss developer Otonomy closed its doors. What does this mean for people with hearing loss who are hoping for a solution?
)
ReSound has extended its OMNIA family of receiver-in-Ear (RIE) products to include Behind-the-Ear (BTE) models and GN’s smallest rechargeable hearing aid yet, the miniRIE, as well as custom in-ear products. OMNIA is designed to address the #1 hearing aid challenge: hearing speech in noise.
)
Switzerland-based hearing healthcare giant Sonova has introduced SilentCloud, a subscription-based medical app to empower patients to manage their tinnitus symptoms at home using scientifically validated approaches for tinnitus management with trained hearing care experts for guidance.
)
MDHearing, a manufacturer of affordable over-the-counter (OTC) hearing aids, has teamed with Medline to take advantage of something new: supplemental health insurance coverage for purchase of OTC hearing aids.
)
An international team of researchers led by Andrea Soddu at Western University in Canada has developed a new classification procedure for tinnitus patients using data acquired by electroencephalography (EEG), which measures electrical activity in the brain using small electrodes placed on the scalp.
)
)